Arca
Skip to content
Tools
Tools

-grastim

A G-CSF: raises the number of neutrophils, often after chemotherapy.

  • Drugs ending in -grastim: 11
  • Approved somewhere: 6
  • With a US drug page: 2

What it means

Stem from WHO's stem book, 2024; description by Arca
Stem
-grastim
Class
Versions of G-CSF, which boosts neutrophils
Sub-stem of
-stim: Colony-stimulating factors, which boost blood cell production
Most common targets
CSF3R (8)

Drugs that carry it

Approved and clinical-stage drugs in ChEMBL whose names ending in -grastim, matched by spelling; those with a US drug page link to it.
Acts on
Efbemalenograstim alfaApprovedCSF3RGranulocyte colony stimulating factor receptor agonist
EflapegrastimApprovedCSF3RGranulocyte colony stimulating factor receptor agonist
FilgrastimApprovedCSF3RGranulocyte colony stimulating factor receptor agonist
LenograstimApprovedCSF3RGranulocyte colony stimulating factor receptor agonist
LipegfilgrastimApprovedCSF3RGranulocyte colony stimulating factor receptor agonist
PegfilgrastimApprovedCSF3RGranulocyte colony stimulating factor receptor agonist
BalugrastimPhase 2CSF3RGranulocyte colony stimulating factor receptor agonist
MecapegfilgrastimPhase 2——
PegteograstimPhase 2CSF3RGranulocyte colony stimulating factor receptor agonist
Empegfilgrastim———
Pegbovigrastim——Unknown

Stem from WHO, The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (2024); description written by Arca. Drugs, stages, targets and mechanisms from ChEMBL (CC BY-SA 3.0). WHO

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.